UltraGreen.ai shares down 9.7% after guiding for lower FY2026 revenue
This comes amid increased uncertainty in the US operating environment and entry of competing products
[SINGAPORE] Shares of UltraGreen.ai dipped 9.7 per cent on market open, after the company announced it expects its FY2026 revenue to fall short of guidance.
The counter opened at US$0.51 on Thursday (Oct 29), around 10 per cent lower than its previous closing price of US$0.565.
As at 9.08 am, shares of the medtech platform traded at US$0.54, with about 355,500 shares being traded at a cumulative value of US$184,405.
In a Q3 business update on Thursday, the medtech platform expects its FY2026 revenue to come in below its previous guidance of US$175 million to US$185 million, with the impact forecast to continue into FY 2027.
UltraGreen.ai’s Q3 revenue rose 43.9 per cent to US$44.6 million, from US$31 million in the corresponding period the previous year.
The reduced guidance comes amid increased uncertainty in the US operating environment. The entry of competing indocyanine green (ICG) products has resulted in pricing pressures and changes in customer purchasing patterns.
UltraGreen.ai was listed on the mainboard of the Singapore Exchange in December 2025 at US$1.45.
